CARsgen Therapeutics Holdings Ltd
CARsgen Therapeutics Holdings's GHG Emissions Data Preview
In 2023, CARsgen Therapeutics Holdings completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, CARsgen Therapeutics Holdings has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Verified Sources Behind CARsgen Therapeutics Holdings’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore CARsgen Therapeutics Holdings’s data sources below and access millions more through our Disclosure Search.
Insights into CARsgen Therapeutics Holdings's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of CARsgen Therapeutics Holdings amounted to 15,327.77 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of CARsgen Therapeutics Holdings decreased by 10.78%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
CARsgen Therapeutics Holdings's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are CARsgen Therapeutics Holdings's Scope 1 emissions?
In 2023, the total Scope 1 emissions of CARsgen Therapeutics Holdings were 3,639.12 metric tons of CO₂ equivalent (tCO₂e). a
Has CARsgen Therapeutics Holdings reduced its Scope 1 emissions over time?
Since 2021, CARsgen Therapeutics Holdings's Scope 1 emissions have increased by 3,007.7%, reflecting a rising long-term trend in Scope 1 emissions over time. a
Compared to the previous year (2022), CARsgen Therapeutics Holdings's Scope 1 emissions decreased by 27.68%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
What are CARsgen Therapeutics Holdings's Scope 2 emissions?
In 2023, CARsgen Therapeutics Holdings reported Scope 2 greenhouse gas (GHG) emissions of 11,688.65 tCO₂e without specifying the calculation method. a
Has CARsgen Therapeutics Holdings reduced its Scope 2 emissions over time?
Since 2021, CARsgen Therapeutics Holdings's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have increased by 26.11%, reflecting a rising long-term trend in Scope 2 emissions over time. a
Compared to the previous year (2022), CARsgen Therapeutics Holdings's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that CARsgen Therapeutics Holdings 's emissions have plateaued with no significant change in its energy consumption footprint. a
What methodology does CARsgen Therapeutics Holdings use for Scope 2 reporting?
In 2023, CARsgen Therapeutics Holdings reported its Scope 2 emissions using an unspecified methodology. a
CARsgen Therapeutics Holdings's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into CARsgen Therapeutics Holdings’s GHG Emissions Intensity Compared to Industry Peers
In 2021, CARsgen Therapeutics Holdings reported Scope 1 greenhouse gas (GHG) emissions of 117.1 tCO₂e and total revenues of USD 4 millions. This translates into an emissions intensity of 28.91 tCO₂e per millions USD. a
CARsgen Therapeutics Holdings's Scope 1 Emissions Intensity Compared to Peers
How does CARsgen Therapeutics Holdings's GHG emissions intensity compare to its peers?
In 2021, CARsgen Therapeutics Holdings reported a Scope 1 emissions intensity of 28.91 tCO₂e per millions USD. Compared to the peer group median of 8.49 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does CARsgen Therapeutics Holdings rank on GHG emissions intensity within its industry?
In 2021, CARsgen Therapeutics Holdings ranked 20 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places CARsgen Therapeutics Holdings among the least efficient performers, with one of the highest emissions intensities in its sector. a